Your Article Summary
Novartis begins shipment of Fluvirin seasonal influenza vaccine for the U.S. market ahead of schedule
Novartis, 08/06/09
Novartis Vaccines has started shipping seasonal influenza vaccine to U.S. healthcare facilities for the 2009–2010 season. The company delivered Fluvirin influenza virus vaccine, which has been approved by the U.S. Food and Drug Administration, to the U.S. weeks ahead of schedule in anticipation of the increased demand for seasonal influenza vaccine created by the current global H1N1 influenza pandemic.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon, 12/15/09
Hospira Buys Infection Control Vendor
HealthDataManagement, 12/11/09
Mediware Makes Two Buys
HealthDataManagement, 12/10/09
Article Search
Sponsor


See Latest Articles


